%0 Journal Article %T [Hematopoietic stem cell transplantation ocular complications: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]. %A Borel C %A Ahmad I %A Ceballos P %A Desbrosses Y %A Hamzy F %A Ravinet A %A Souchet L %A Turlure P %A Villate A %A Yakoub-Agha I %A Guillaume T %J Bull Cancer %V 107 %N 12 %D Dec 2020 %M 32631612 %F 1.318 %R 10.1016/j.bulcan.2020.04.014 %X BACKGROUND: Allogeneic stem cell transplantation is currently the only curative therapy for hematological disorders. This treatment can lead to complications, of which ophtalmological involvement.
METHODS: We reviewed the literature and established accessible and convenient recommendations for hematologists and ophthalmologists.
RESULTS: Ophtalmological follow-up should be done in every patient having had an allogeneic transplantation, by the hematologist questioning and by the ophthalmologist physical exam. Complications due to graft-versus-host disease (GVHD) or not due to GVHD are cited, as well as therapeutic options.
CONCLUSIONS: Screening and treatment of ophthalmologic complications in allogeneic stem cells transplantation recipients requires a close collaboration between hematologists and ophthalmologists. The management of these patients by caregivers trained in these questions is encouraged.